Previous studies evaluating the efficacy of URIL with AID systems in type 1 diabetes employed a hybrid closed‐loop approach or compared fully closed‐loop insulin delivery with standard (non‐AID) insulin pump therapy.10, 11. This evidence concerns the gene INS and type 1 diabetes mellitus.